Antitumour activity of dopa, dopamine, noradrenalin or adrenalin and their reaction with nucleic acids.
D000818:Animals; D002395:Catecholamines / Q000494:pharmacology* / Q000627:therapeutic use; D002850:Chromatography, Gel; D002854:Chromatography, Paper; D003300:Copper / Q000494:pharmacology; D004273:DNA, Neoplasm / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D008297:Male; D051379:Mice; D009638:Norepinephrine / Q000494:pharmacology; D009691:Nucleic Acid Denaturation / Q000187:drug effects*; D009711:Nucleotides / Q000494:pharmacology; D012334:RNA, Neoplasm / Q000378:metabolism; D012510:Sarcoma 180 / Q000378:metabolism; D012513:Sarcoma, Experimental / Q000188:drug therapy / Q000378:metabolism*; D013057:Spectrum Analysis; D014783:Viscosity
D002395:Catecholamines; D004273:DNA, Neoplasm; D009711:Nucleotides; D012334:RNA, Neoplasm; D004295:Dihydroxyphenylalanine; D003300:Copper; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine